AAAAAA

   
Results: 1-7 |
Results: 7
POTENTIAL IMPACT ON SURVIVAL OF IMPROVED TUMOR DOWNSTAGING AND RESECTION RATE BY PREOPERATIVE TWICE-DAILY RADIATION AND CONCURRENT CHEMOTHERAPY IN STAGE IIIA NON-SMALL-CELL LUNG-CANCER
Authors: CHOI NC CAREY RW DALY W MATHISEN D WAIN J WRIGHT C LYNCH T GROSSBARD M GRILLO H
Citation: Nc. Choi et al., POTENTIAL IMPACT ON SURVIVAL OF IMPROVED TUMOR DOWNSTAGING AND RESECTION RATE BY PREOPERATIVE TWICE-DAILY RADIATION AND CONCURRENT CHEMOTHERAPY IN STAGE IIIA NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 15(2), 1997, pp. 712-722
PROSPECTIVE-STUDY OF PRE-ADJUVANT AND POST-ADJUVANT TREATMENT EUS IN PATIENTS WITH ESOPHAGEAL CANCER
Authors: QUIRK D LYNCH T GROSSBARD M BRUGGE W
Citation: D. Quirk et al., PROSPECTIVE-STUDY OF PRE-ADJUVANT AND POST-ADJUVANT TREATMENT EUS IN PATIENTS WITH ESOPHAGEAL CANCER, Gastrointestinal endoscopy, 45(4), 1997, pp. 612-612
ASSESSMENT OF PREOPERATIVE ACCELERATED RADIOTHERAPY AND CHEMOTHERAPY IN STAGE IIIA (N2) NON-SMALL-CELL LUNG-CANCER
Authors: MATHISEN DJ WAIN JC WRIGHT C CHOI N CAREY R HILGENBERG A GROSSBARD M LYNCH T GRILLO H
Citation: Dj. Mathisen et al., ASSESSMENT OF PREOPERATIVE ACCELERATED RADIOTHERAPY AND CHEMOTHERAPY IN STAGE IIIA (N2) NON-SMALL-CELL LUNG-CANCER, Journal of thoracic and cardiovascular surgery, 111(1), 1996, pp. 123-131
TREATMENT OF THE CHRONIC PHASE OF CML WITH A COMBINED CONTINUOUS-INFUSION OF HOMOHARRINGTONINE AND CYTARABINE
Authors: ERNST TJ SHULMAN LN GROSSBARD M
Citation: Tj. Ernst et al., TREATMENT OF THE CHRONIC PHASE OF CML WITH A COMBINED CONTINUOUS-INFUSION OF HOMOHARRINGTONINE AND CYTARABINE, Blood, 86(10), 1995, pp. 2106-2106
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN POOR-PROGNOSIS INTERMEDIATE-GRADE AND HIGH-GRADE B-CELL NON-HODGKINS-LYMPHOMA IN 1ST REMISSION - A PILOT-STUDY
Authors: FREEDMAN AS TAKVORIAN T NEUBERG D MAUCH P RABINOWE SN ANDERSON KC SOIFFER RJ SPECTOR N GROSSBARD M ROBERTSON MJ BLAKE K CORAL F CANELLOS GP RITZ J NADLER LM
Citation: As. Freedman et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN POOR-PROGNOSIS INTERMEDIATE-GRADE AND HIGH-GRADE B-CELL NON-HODGKINS-LYMPHOMA IN 1ST REMISSION - A PILOT-STUDY, Journal of clinical oncology, 11(5), 1993, pp. 931-936
A PHASE-II STUDY OF CONTINUOUS-INFUSION RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) AS AN ADJUNCT TO AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR NON-HODGKINS-LYMPHOMA (NHL) IN 1ST REMISSION
Authors: ODAY S RABINOWE S NEUBERG D FREEDMAN A SOIFFER R ROBERTSON M SPECTOR N GROSSBARD M ANDERSON K WHELAN M PESEK K RITZ J NADLER L
Citation: S. Oday et al., A PHASE-II STUDY OF CONTINUOUS-INFUSION RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) AS AN ADJUNCT TO AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR NON-HODGKINS-LYMPHOMA (NHL) IN 1ST REMISSION, Blood, 82(10), 1993, pp. 10000145-10000145
USE OF ANTI-B4-BLOCKED RICIN AS AN IMMUNOSUPPRESSANT
Authors: ESSELTINE DL BRAMAN GM PARK Y LEVINE AM MCLAUGHLIN P MURRAY JL GROSSBARD M LYNCH T RITZ J NADLER L EPSTEIN CL
Citation: Dl. Esseltine et al., USE OF ANTI-B4-BLOCKED RICIN AS AN IMMUNOSUPPRESSANT, Blood, 82(10), 1993, pp. 10000240-10000240
Risultati: 1-7 |